Database of mammalian genes
Home
Search
Browse
Statistics
User guide
FAQs
Links
Questions
Contribute
Download
Search by condition, location and species
Select species
Bos taurus
Homo sapiens
Mus musculus
Rattus norvegicus
Sus scrofa
Select strain
Holstein
Holstein-Friesian
Select subspecies2
Select subspecies2
Select population
African American
American Indian
Asian
Black
Caucasian
Caucasian+Oriental
Chinese
Finnish
Hispanic
Japanese
Korean
Mixed
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Afro-American+White
Select subspecies3
Select strain
129/SvTer
C57BL/6J
C57BL6
CD1
FVB
ICR
K14E6
Kunming White
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select subspecies2
Select strain
Long Evans
Sprague-Dawley
Select subspecies2
Select subspecies2
Select strain
Landrace
Yorkshire
Select subspecies2
Select subspecies2
Uterus
Select sub-tissue
Cervix
Corpus
Endometrium
Endomyometrium
Myometrium
Uterine horn(s)
Uterine lumen
Select sub-tissue1
Ecto/Endo cervix
Ectocervix
Endocervix
Select sub-tissue2
Select sub-tissue2
Select sub-tissue2
Canal
Select sub-tissue3
Select sub-tissue1
Myometrium
Select sub-tissue2
Select sub-tissue1
Decidua
Ectopic
Intercaruncle
Next level
Select sub-tissue2
Select sub-tissue2
Select sub-tissue2
Select sub-tissue2
Menstrual
Proliferative (Follicular)
Proliferative+Secretory
Proliferative/Secretory
Secretory (Luteal)
Select sub-tissue3
Day 2-5
Select sub-tissue3
Early
Late
Mid
Mid-late
Next level
Select sub-tissue3
Select sub-tissue3
Day 8-12/No data; LH+1-5
Select sub-tissue3
Early (Pre-receptive)
Late (Non-receptive)
Mid (Receptive)
Select sub-tissue1
Select sub-tissue1
Select sub-tissue1
Select sub-tissue1
Implantation site
Inter-implantation site
Select sub-tissue2
Select sub-tissue2
Select cell-type
Epithelial cell
Mixed
Smooth muscle cell
Stromal cell
sub cell-type1
Columnar
Squamous
sub cell-type2
Glandular
sub cell-type3
sub cell-type2
Basal
Basal/Parabasal
Endothelial
Keratinocyte
sub cell-type3
Keratinocyte
sub cell-type4
sub cell-type3
sub cell-type3
sub cell-type3
sub cell-type1
Epithelial (glandular)+Stromal
sub cell-type2
sub cell-type1
sub cell-type1
Fibroblast
sub cell-type2
Select condition
Chemical treatment
Chemoradiation
Control
Cultured cells
Disease
Genetics
Hormone treatment
May be normal
Normal
Others
Radiation treatment
Specific gene study
Thermochemoradiation
------Any------
5-Fluorouracil
BBR3464
Bisphenol A
Calcium
Camptothecin
Celecoxib
Cisplatin
Doxycycline
Gefitinib
LTK-14
Mifepristone
NNK
P-tert-octylphenol
Tamoxifen
Trichostatin A
------Any------
NULL
0,5 miM
0.5 miM
4000 mg/m2
------Any------
------Any------
------Any------
------Any------
3
------Any------
4 Days, NULL
------Any------
0.3 mig/ml
10 mig/ml
------Any------
------Any------
------Any------
1 miM
1 pM
10 nM
100 pM
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
1.4 mM
------Any------
1
------Any------
24 Hours, NULL
------Any------
10 miM
400 mg
------Any------
1
------Any------
8 Hours, NULL
------Any------
1
------Any------
NULL, NULL
------Any------
400 mg/day
------Any------
2
------Any------
1 Years, NULL
------Any------
NULL
1 miM
10 miM
30 mig/ml
75 mg/m2
75 mig/ml
------Any------
------Any------
------Any------
------Any------
1
------Any------
1 Hours, NULL
24 Hours, NULL
------Any------
3
------Any------
4 Hours, NULL
------Any------
1
------Any------
1 Hours, NULL
24 Hours, NULL
------Any------
NULL
2 mig
------Any------
------Any------
------Any------
1 miM
------Any------
1
------Any------
12 Hours, NULL
24 Hours, NULL
------Any------
100 miM
------Any------
------Any------
10 miM
100 nmol/L
8 mg/kg
------Any------
1
------Any------
4 Hours, NULL
4 Months, NULL
------Any------
------Any------
2
------Any------
8 Hours, NULL
------Any------
1 miM
10 miM
100 miM
------Any------
1
------Any------
12 Weeks, NULL
------Any------
1
------Any------
12 Weeks, NULL
------Any------
1
------Any------
12 Weeks, NULL
------Any------
125 mg/kg
------Any------
1
35
------Any------
24 Hours, NULL
------Any------
NULL, NULL
------Any------
1 mg/kg
10-6 M
20 mg/day
250 mg/kg
5 miM
------Any------
1
------Any------
1-4 Days,3 Months
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
------Any------
1460-1825
------Any------
4-5 Years, NULL
------Any------
1
------Any------
1-4 Days,3 Months
------Any------
1
------Any------
3 Hours, NULL
------Any------
0.3 mig/L
0.5 mig/L
300 nmol/L
------Any------
1
------Any------
48 Hours, NULL
------Any------
1
------Any------
48 Hours, NULL
------Any------
1
------Any------
1 Days, NULL
------Any------
(5FU+Cisplatin)+X-rays
Cisplatin+X-rays
------Any------
No data + 45 Gy
------Any------
No data + 1/day
------Any------
------Any------
40mg/m2 + 50 Gy
40mg/m2 + 9 Gy
------Any------
6 + 5
------Any------
------Any------
1 + 1
------Any------
7 days
------Any------
Empty vector
siRNA-Control
Vehicle treated
------Any------
pcDNA3.0
------Any------
------Any------
------Any------
Oil
Solvent
------Any------
Sesame oil
------Any------
8 mg/kg
Next level
------Any------
DMSO
Ethanol
------Any------
0.1 %
Next level
------Any------
0.1 %
0.2 %
100 %
Next level
------Any------
0 hour
1 day
1 hour
3 hours
30 min
5 hours
7 hours
9 hours
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
Cancer
Carcinoma in situ
Cervicitis
CIN/Cervical dysplasia
Endometrial hyperplasia
Endometriosis
Leiomyoma
------Any------
Cervical cancer
Endometrial cancer
Leiomyosarcoma
Uterine sarcoma
------Any------
Cervical carcinoma
Multiple type
------Any------
Adenocarcinoma
Adenosquamous
Multiple type
Squamous cell
------Any------
SCC+AC+MMMT
------Any------
Endometrial carcinoma
Endometrial sarcoma
------Any------
Adenocarcinoma
Endometrioid
Mixed carcinoma
Non-endometrioid
------Any------
------Any------
MMT
------Any------
------Any------
------Any------
------Any------
------Any------
HG-SIL
HSIL
LG-SIL
------Any------
------Any------
------Any------
------Any------
Complex non-atypical
------Any------
------Any------
Colorectal
Intestinal
Multiple type
Ovarian
Peritoneal
------Any------
------Any------
------Any------
Ovarian+Peritoneal
------Any------
------Any------
Endometrioma
------Any------
------Any------
Endometrial implants
------Any------
------Any------
------Any------
del(7q)
IL11Ra-/-
LOH (1q)
PRCre/+;COUP-TFIIflox/flox
Pten+/-; Mlh1+/+
Pten+/-; Mlh1-/-
TIMP1-/TIMP1-
Tsc-2Ek/+
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
5 alpha Dihydrotestosterone
E2+(E2+P)
E2+P4
Estradiol
Estrogen
hCG
ICI 182,780
P4+(E2+P4)
Progesterone
------Any------
0.1 mg
------Any------
1
------Any------
1 Hours, NULL
12 Hours, NULL
18 Hours, NULL
24 Hours, NULL
3 Hours, NULL
6 Hours, NULL
------Any------
NULL
------Any------
------Any------
NULL
------Any------
------Any------
NULL
0.05 mig
0.1 mg/kg
1 mg
1 miM
1 mM
1 nmol/L
1 pM
1+.0000067 mg
1+.0000067 NULL
10 mig/kg
10 nM
10-8 M
100 mg/kg
100 ng
100 nM
100 pM
2 mg
2.5 mig/ml
25 ng
300 ng
385 mg/kg
5 mig/kg
50 ng
------Any------
NULL, NULL
1
------Any------
------Any------
0.5 Hours, NULL
12 Hours, NULL
2 Hours, NULL
24 Hours, NULL
6 Hours, NULL
------Any------
1
------Any------
1 Hours,NULL NULL
12 Hours,NULL NULL
24 Hours,NULL NULL
3 Hours,NULL NULL
6 Hours,NULL NULL
------Any------
1
3
------Any------
12 Hours, NULL
2 Hours, NULL
24 Hours, NULL
8 Hours, NULL
------Any------
24 Hours, NULL
------Any------
1
------Any------
1 Days, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
2
------Any------
2 Days, NULL
------Any------
2
------Any------
2 Days, NULL
------Any------
1
3
------Any------
24 Hours, NULL
6 Hours, NULL
------Any------
72 Hours, NULL
------Any------
1
------Any------
12-15 Days, NULL
2-4 Days, NULL
24 Hours, NULL
4-6 Days, NULL
48 Hours, NULL
6-9 Days, NULL
8 Hours, NULL
9-12 Days, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
------Any------
1
------Any------
1-4 Days,3 Months
------Any------
1
------Any------
2 Days, NULL
------Any------
1
------Any------
3 Hours, NULL
------Any------
1
------Any------
24 Hours, NULL
48 Hours, NULL
8 Hours, NULL
------Any------
21
------Any------
21 Days, NULL
------Any------
1
------Any------
2 Hours, NULL
24 Hours, NULL
------Any------
1
------Any------
12 Hours, NULL
------Any------
1
------Any------
12 Hours, NULL
6 Hours, NULL
------Any------
1
------Any------
1-4 Days,3 Months
------Any------
1
------Any------
6 Hours, NULL
------Any------
1
------Any------
NULL, NULL
------Any------
NULL
------Any------
2
------Any------
NULL, NULL
------Any------
NULL
0.25 mg
10000 IU
NULL NULL
------Any------
2 Days, NULL
5 Days, NULL
------Any------
------Any------
------Any------
------Any------
NULL, NULL
1
------Any------
------Any------
36 Hours, NULL
------Any------
------Any------
250 ng/kg
------Any------
1
------Any------
6 Hours, NULL
------Any------
1+(0.00005+1) NULL
------Any------
3+(1)
------Any------
3+(1) Days, NULL
------Any------
NULL
0.0000001 M
1 miM
10 miM
2 NULL
30 mig/ml
30 nM
------Any------
NULL, NULL
------Any------
------Any------
------Any------
1
------Any------
12-15 Days, NULL
2-4 Days, NULL
4-6 Days, NULL
6-9 Days, NULL
9-12 Days, NULL
------Any------
1
------Any------
4 Hours, NULL
------Any------
3
------Any------
3 Days, NULL
------Any------
1
------Any------
4 Hours, NULL
------Any------
1
------Any------
12 Hours, NULL
------Any------
Empty vector
Patient
Surgery
Vehicle treated
------Any------
pLXSN
------Any------
------Any------
Non uterus-related disorder
Tissue (not sure) disorder
Uterus & non-uterus related disorder
Uterus-related disorder
------Any------
Cystocele
Non-malignant
Ovarian cyst
PCOS
------Any------
------Any------
------Any------
------Any------
------Any------
Infertility
------Any------
------Any------
Multiple disorders
------Any------
------Any------
Benign disease
Endometriosis
Endometriosis/Fibroids
Non-malignant
Prolapse
Tumor(s)
------Any------
Endometrial polyp
Menorrhagia/dysmenorrhoea
Uterine myoma
Uterine myomatosis+CIN (grade III)
Uterus fibromatosis
------Any------
Multiple type
Ovarian
Peritoneal
------Any------
------Any------
------Any------
Uterine myoma
------Any------
------Any------
Oophorectomy
Sham
------Any------
Bilateral salpingo
------Any------
------Any------
------Any------
Next level
Oil
Saline
Solvent
------Any------
Ethanol+methylcellulose
------Any------
5%+0.4%
------Any------
Corn oil
Next level
Sesame oil
------Any------
Next level
------Any------
5 mig/kg
------Any------
0.1 ml
Next level
------Any------
Next level
PBS
------Any------
100 μl
------Any------
------Any------
Propylene glycol
------Any------
------Any------
------Any------
Antibody resistance
Antibody treatment
Artificial decidualization
Artificial insemination
Contraception
Cytokine treatment
Drug resistance
Embryo implantation
Embryos transfer/implantation
Experimental variation
Genetic ablation
Gestation
Growth conditions
Growth factor treatment
Habits
Implantation window
Induced endometriosis
IVF treatment
LPS treatment
Metastatic tumor(s)
miRNA transfection
Negative energy balance (NEB)
Patient (other disorders)
Post parturition
Pseudopregnancy
Reference RNA
Response to therapy
Subjects with metastasis
Surgery
Viral infection
------Any------
CH-11
------Any------
------Any------
Monoclonal (mAb)
------Any------
CH-11
------Any------
100 ng/ml
------Any------
Sesame oil
------Any------
10 μl
20 μl
------Any------
1
------Any------
1
------Any------
Inactivated semen
------Any------
------Any------
IUD
------Any------
1 month
------Any------
12 months
2 months
------Any------
IFN-α
IFN-β
IL-11
rhTNFα
TGF-β2
TNFα
------Any------
1000 U/ml
------Any------
6 hours
------Any------
300 U/ml
500 U/ml
------Any------
------Any------
------Any------
100 ng/ml
------Any------
10-12 days
------Any------
25 ng/ml
------Any------
0 hour
1 hour
3 hours
6 hours
------Any------
1.0 ng/ml
------Any------
24 hours
------Any------
0.1 ng/ml
1 nM
------Any------
4 hours
------Any------
4 - 6 hours
------Any------
Cisplatin
------Any------
------Any------
Delayed
Delayed & reactivated
------Any------
Oophorectomy + P4
------Any------
------Any------
P4; 17β-estradiol
------Any------
------Any------
(Mus musculus - ICR)+(Rattus norvegicus - Wistar)
Mus musculus - ICR
Rattus norvegicus - Wistar
------Any------
(4 days)+(5 days)
------Any------
3 days
------Any------
3 days
4 days
------Any------
4 days
------Any------
3 days
------Any------
5 days
------Any------
3 days
------Any------
Amplification method
RNA conc.
------Any------
Standard
------Any------
------Any------
High
Low
------Any------
5 mig
------Any------
15 ng
2.0 mig/mil
5.0 mig/mil
------Any------
COUP-TFII
------Any------
------Any------
14 days
25 days
3.5 days
35-40 weeks
37-42 weeks
39-40 weeks
4 days
4.5 days
5 days
7.5 days
In labour
Not in labour
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
Growth factor deprivation
Low-growth conditions
Standard conditions
------Any------
EGF+BPE+Insulin+Cortisol+T3+Transferrin
------Any------
24 hours
------Any------
1% FCS+(No growth factors)
------Any------
------Any------
5% FCS+(FGF+Steroids+EGF)
------Any------
------Any------
EGF
------Any------
10 ng/ml
30 ng/ml
------Any------
0 min
2 hours
20 min
4 hours
40 min
60 min
8 hours
------Any------
12 hours
24 hours
------Any------
Alcohol consumption
No alcohol consumption
Non-smoker
Smoker
------Any------
------Any------
------Any------
------Any------
11-15 years
16-20 years
21-25 years
26-30 years
31-35 years
36-40 years
6-10 years
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
Autotransplantation
Sub-peritoneal inoculation
------Any------
2 days
24 hours
29 days
3 days
60 days
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
4 weeks
6 weeks
------Any------
------Any------
------Any------
Oocyte retrieval
------Any------
------Any------
E. coli serotype 0111: B4
------Any------
10 ng ⁄ml
------Any------
------Any------
Lymph node
Omentum
Small intestine
------Any------
------Any------
------Any------
------Any------
Lipofectamine
------Any------
48 hours
------Any------
------Any------
Mild-NEB
Severe-NEB
------Any------
12 days
------Any------
------Any------
12 days
------Any------
------Any------
Tissue (not sure) disorder
Uterus-relared disorder
------Any------
Infertility
------Any------
------Any------
Benign disease
Prolapse
------Any------
Uterine myomatosis+CIN (grade III)
------Any------
------Any------
1-2 hours
14 days
------Any------
------Any------
------Any------
13 days
15 days
3 days
------Any------
------Any------
------Any------
------Any------
Custom Reference RNA
Standard RNA
Standard Uterus RNA
Universal human reference RNA
Universal mouse reference RNA
Universal reference RNA
------Any------
RNA pool - 25 normal tissues
RNA pool - Endometrial samples
------Any------
------Any------
------Any------
Clontech
------Any------
------Any------
BD Biosciences
Clontech
Strategene
------Any------
------Any------
------Any------
------Any------
Stratagene
------Any------
------Any------
------Any------
CRG
Stratagene
------Any------
------Any------
------Any------
Chemoradiation
COS cycle(s)
IVF
Radiation
Surgery
Thermoradiation
------Any------
NED (positive)
Partial remission
Recurrent (negative)
------Any------
------Any------
------Any------
------Any------
Excessive
Moderate
------Any------
Serum E2 ≤20,000 pmol/L
Serum E2 >20,000 pmol/L
------Any------
Serum E2 ≤20,000 pmol/L
------Any------
Implantation failure
Miscarriage
RSA
Successful pregnancy
------Any------
< 12 weeks
------Any------
< 12 weeks
------Any------
------Any------
------Any------
Complete response
Died of disease
Metastasis negative
Metastasis positive
No change
No evidence of disease
Resistant
Sensitive
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
NED (positive)
Recurrent (negative)
------Any------
------Any------
------Any------
Complete response
No change
------Any------
------Any------
------Any------
Bone
Liver
Lungs
Lymph node
Omentum
Peritoneum
Pulmonary
Retroperitoneum
------Any------
------Any------
------Any------
------Any------
Supraclavicular
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
Lymphadenectomy
Oophorectomy
------Any------
Bilateral pelvic
------Any------
------Any------
Bilateral salpingo
------Any------
------Any------
Artificial
CVB3
HPV/HPV16
HPV/HPV16/HPV18
HPV16/HPV18
Natural
------Any------
AAV-2
------Any------
------Any------
45 min
------Any------
10 MOI
------Any------
------Any------
------Any------
------Any------
HPV
HPV-18+partial HPV-45
HPV16
HPV16+HPV18
HPV16+HPV18+HPV31+HPV45
HPV16+HPV31+HPV45
HPV16+HPV33
HPV16/HPV18
HPV16/HPV18/HPV31/HPV33
HPV16/HPV18/HPV31/HPV52/HPV58
HPV16/HPV18/HPV45/HPV73
HPV18
HPV18+HPV45
HPV18/HPV31/HPV52/HPV58
HPV31
HPV33
HPV33+HPV52+HPV58
HPV35
HPV39
HPV45
HPV56
HPV58
HPV58/70
HPV59
HPV66
HPV67
HPV69
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
------Any------
X-rays
------Any------
45 Gy
6 Gy
64-66 Gy
9 Gy
------Any------
25
------Any------
25 days
------Any------
1
------Any------
1 hour
7 days
------Any------
1
------Any------
56-60 days
------Any------
1
------Any------
7 days
------Any------
KIKO
Knockout
Mutation
Transfection
------Any------
ERα
------Any------
------Any------
CHD8
ERalpha
------Any------
------Any------
------Any------
COUP-TFII
FH
Tsc2
------Any------
------Any------
------Any------
------Any------
ATF2
ATF2-small gene
CA9
CREB
CREM tau2α
CREMα
E6 siRNA
HOXA10
HPV18 E2
HPV18 E2-delTAD
HPV18 E2-TAD
IκBα
mTOR siRNA
NASP siRNA
PR-A
PR-B
PTEN
rat anti-KLF9
rat KLF9
siDGCR8
siDrosha
siGFP
siRNA-LATS1+siRNA-LATS2
SRA siRNA
STAU1 siRNA
tNASP
Viral E6
ZBRK1
------Any------
pcDNA3.1/V5 His TOPO+TransIT-LT1
------Any------
52 hours
------Any------
pcDNA3.1/V5 His TOPO+TransIT-LT1
------Any------
52 hours
------Any------
pcDNA3.0
------Any------
------Any------
pcDNA3.1/V5 His TOPO+TransIT-LT1
------Any------
52 hours
------Any------
pcDNA3.1/V5 His TOPO+TransIT-LT1
------Any------
52 hours
------Any------
pcDNA3.1/V5 His TOPO+TransIT-LT1
------Any------
52 hours
------Any------
Lipofectamine
Oligofectamine
------Any------
24 hours
------Any------
48 hours
------Any------
Next level
------Any------
48 hours
------Any------
Adenovirus
------Any------
1 hour
40 hours
------Any------
Adenovirus
------Any------
1 hour
40 hours
------Any------
Adenovirus
------Any------
40 hours
------Any------
pBI-EGFP
------Any------
------Any------
Lipofectamine
------Any------
24 hours
------Any------
Lipofectamine
------Any------
90 hours
------Any------
Adenovirus
------Any------
Overnight
------Any------
Adenovirus
------Any------
Overnight
------Any------
Adenovirus
------Any------
1 hour
------Any------
------Any------
------Any------
Lipofectamine
------Any------
24 hours
48 hours
------Any------
Lipofectamine
------Any------
24 hours
48 hours
------Any------
Lipofectamine
Oligofectamine
------Any------
24 hours
48 hours
------Any------
48 hours
------Any------
Lipofectamine
------Any------
2 days
------Any------
TransIT-TKO
------Any------
3 days
------Any------
------Any------
pEGFP-N1
------Any------
------Any------
------Any------
------Any------
X-rays+Cisplatin+Hyperthermia
------Any------
55.8 Gy + 40 mg/m2 + 41.5c
------Any------
25 + 5 + 5
------Any------
5 wks + 5 wks + 15 hrs
Search by gene(s)*
Entrez GeneID
Gene symbol
Keyword/Gene name/Synonym
*Separate words by "," (comma); do not use space
